Fevertree Drinks Plc (FEVR) is a leading beverages-non-alcoholic business based in the UK. Fevertree Drinks is listed on the London Stock Exchange (LSE) and employs 180 staff. All prices are listed in pence sterling.
|52-week range||881.228p - 2587p|
|50-day moving average||2381.7354p|
|200-day moving average||1355.2416p|
|Wall St. target price||3749.29p|
|Dividend yield||0.15p (0.66%)|
|Earnings per share (TTM)||40.9p|
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Fevertree Drinks stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Fevertree Drinks's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Fevertree Drinks's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 57x. In other words, Fevertree Drinks shares trade at around 57x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
However, Fevertree Drinks's P/E ratio is best considered in relation to those of others within the beverages-non-alcoholic industry or those of similar companies.
Fevertree Drinks's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £61.6 million.
The EBITDA is a measure of a Fevertree Drinks's overall financial performance and is widely used to measure a its profitability.
To put Fevertree Drinks's EBITDA into context you can compare it against that of similar companies.
|Revenue TTM||£247.4 million|
|Operating margin TTM||23.77%|
|Gross profit TTM||£131.5 million|
|Return on assets TTM||14.59%|
|Return on equity TTM||22.08%|
|Market capitalisation||£2.7 billion|
TTM: trailing 12 months
Dividend payout ratio: 3729.27% of net profits
Recently Fevertree Drinks has paid out, on average, around 3729.27% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.66% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Fevertree Drinks shareholders could enjoy a 0.66% return on their shares, in the form of dividend payments. In Fevertree Drinks's case, that would currently equate to about 0.15p per share.
Fevertree Drinks's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 24 September 2020 (the "ex-dividend date").
Fevertree Drinks's dividend payout ratio is perhaps best considered in relation to those of similar companies.
Over the last 12 months, Fevertree Drinks's shares have ranged in value from as little as 881.228p up to 2587p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Fevertree Drinks's is 1.1471. This would suggest that Fevertree Drinks's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
To put Fevertree Drinks's beta into context you can compare it against those of similar companies.
Fevertree Drinks Plc, together with its subsidiaries, develops and supplies premium mixer drinks in the United Kingdom, the United States, Europe, and internationally. The company's products include Indian tonic water, Mediterranean tonic water, elderflower tonic water, aromatic tonic water, Clementine tonic water, citrus tonic water lemon tonic water, ginger beer, ginger ale, smoky ginger ale, spiced orange ginger ale, Madagascan cola, Sicilian lemonade, lemonade, and spring soda water. It sells its products under Fever-Tree brand name to bars and restaurants. The company was formerly known as Fevertree Topco Limited and changed its name to Fevertree Drinks Plc in October 2014. Fevertree Drinks Plc was incorporated in 2013 and is headquartered in London, the United Kingdom.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.